These findings suggest that combining metformin with hemin (or any other possible BACH1 inhibitor) would effectively suppress growth of tumors from patients who did not respond to metformin for tumor suppression due to their enriched high BACH1 levels. This evidence concerns the gene BACH1 and neoplasm.